Validation of an in vitro exposure system for toxicity assessment of air-delivered nanomaterials

Toxicology in Vitro

Volumn 27, Issue 1, 2013, Pages 164-173

  Kim, Jong Sung ^a   Peters, Thomas M ^a   O'Shaughnessy, Patrick T ^a   Adamcakova Dodd, Andrea ^a   Thorne, Peter S ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Air liquid interface; Cellular dose; Deposition efficiency; Lung cells; Nanoparticles; Spatial uniformity

Indexed keywords

COPPER NANOPARTICLE; INTERLEUKIN 8; LACTATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE;

AIRBORNE PARTICLE; ANIMAL EXPERIMENT; ARTICLE; CELL SURFACE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSIMETRY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHALATION; LONG TERM EXPOSURE; LUNG ALVEOLUS CELL; MOUSE; NANOANALYSIS; NANOCHEMISTRY; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; VALIDATION PROCESS;

AEROSOLS; AIR; ANIMAL TESTING ALTERNATIVES; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; COPPER; ENDOTOXINS; HUMANS; INTERLEUKIN-8; L-LACTATE DEHYDROGENASE; METAL NANOPARTICLES; REACTIVE OXYGEN SPECIES;

MUS;

EID: 84869478358     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.08.030     Document Type: Article

References (49)

1. Andersen M.E., Krewski D. Toxicity testing in the 21st century: bringing the vision to life. Toxicological Sciences 2009, 107:324-330.
2. Bitterle E., Karg E., Schroeppel A., Kreyling W.G., Tippe A., Ferron G.A., Schmid O., Heyder J., Maier K.L., Hofer T. Dose-controlled exposure of A549 epithelial cells at the air-liquid interface to airborne ultrafine carbonaceous particles. Chemosphere 2006, 65:1784-1790.
3. Card J.W., Zeldin D.C., Bonner J.C., Nestmann E.R. Pulmonary applications and toxicity of engineered nanoparticles. American Journal of Physiology - Lung Cellular and Molecular Physiology 2008, 295:L400-L411.
4. Davoren M., Herzog E., Casey A., Cottineau B., Chambers G., Byrne H.J., Lyng F.M. In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells. Toxicology In Vitro 2007, 21:438-448.
5. Desantes J.M., Margot X., Gil A., Fuentes E. Computational study on the deposition of ultrafine particles from Diesel exhaust aerosol. Journal of Aerosol Science 2006, 37:1750-1769.
6. Donnelly, L.E., 2001. Airway epithelial cells (primaries vs. cell lines). Human airway inflammation. In: Rogers, D.F., Donnelly, L.E. (Eds.), Humana Press, pp. 127-136.
7. Elder A., Vidyasagar S., DeLouise L. Physicochemical factors that affect metal and metal oxide nanoparticle passage across epithelial barriers. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2009, 1:434-450.
8. Elzey S., Grassian V.H. Nanoparticle dissolution from the particle perspective: insights from particle sizing measurements. Langmuir 2010, 26:12505-12508.
9. Fahmy B., Cormier S.A. Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells. Toxicology In Vitro 2009, 23:1365-1371.
10. Fujino N., Kubo H., Suzuki T., Ota C., Hegab A.E., He M., Suzuki S., Suzuki T., Yamada M., Kondo T., Kato H., Yamaya M. Isolation of alveolar epithelial type II progenitor cells from adult human lungs. Lab Invest 2011, 91:363-378.
11. Grassian V.H., Adamcakova-Dodd A., Pettibone J.M., O'Shaughnessy P., Thorne P.S. Inflammatory response of mice to manufactured titanium dioxide nanoparticles: comparison of size effects through different exposure routes. Nanotoxicology 2007, 1:211-226.
12. Grassian V.H., O'Shaughnessy P., Adamcakova-Dodd A., Pettibone J.M., Thorne P.S. Inhalation exposure study of titanium dioxide nanoparticles with a primary particle size of 2-5nm. Environmental Health Perspectives 2007, 115:397-402.
13. Hinderliter P., Minard K., Orr G., Chrisler W., Thrall B., Pounds J., Teeguarden J. ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Particle and Fibre Toxicology 2010, 7:36.
14. Kameyama S., Kondo M., Takeyama K., Nagai A. Air exposure causes oxidative stress in cultured bovine tracheal epithelial cells and produces a change in cellular glutathione systems. Experimental Lung Research 2003, 29:567-583.
15. Karp, P.H., Moninger, T.O., Pary Weber, S., Nesselhauf, T.S., Launspach, J.L., Zabner, J., Welsh, M.J., 2002. An in vitro model of differentiated human airway epithelia. Epithelial cell culture protocols. In: Wise, C. (Ed.), Humana Press, pp. 115-137.
16. Kim J.S., Adamcakova-Dodd A., O'Shaughnessy P., Grassian V., Thorne P. Effects of copper nanoparticle exposure on host defense in a murine pulmonary infection model. Particle and Fibre Toxicology 2011, 8:29.
17. Kroll A., Pillukat M.H., Hahn D., Schnekenburger J. Current in vitro methods in nanoparticle risk assessment: limitations and challenges. European Journal of Pharmaceutics and Biopharmaceutics 2009, 72:370-377.
18. Lenz A., Karg E., Lentner B., Dittrich V., Brandenberger C., Rothen-Rutishauser B., Schulz H., Ferron G., Schmid O. A dose-controlled system for air-liquid interface cell exposure and application to zinc oxide nanoparticles. Particle and Fibre Toxicology 2009, 6:32.
19. Maynard A., Kuempel E. Airborne nanostructured particles and occupational health. Journal of Nanoparticle Research 2005, 7:587-614.
20. Midander K., Cronholm P., Karlsson H.L., Elihn K., Möller L., Leygraf C., Wallinder I.O. Surface characteristics, copper release, and toxicity of nano- and micrometer-sized copper and copper(ii) oxide particles: a cross-disciplinary study. Small 2009, 5:389-399.
21. Muhlfeld C., Rothen-Rutishauser B., Vanhecke D., Blank F., Gehr P., Ochs M. Visualization and quantitative analysis of nanoparticles in the respiratory tract by transmission electron microscopy. Particle and Fibre Toxicology 2007, 4:11.
22. NRC, 2006. Toxicity Testing for Assessment of Environmental Agents: Interim Report.
23. NRC, 2007. Toxicity Testing in the 21st Century: A Vision and a Strategy.
24. Oberdörster G., Oberdörster E., Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environmental Health Perspectives 2005, 113:823-839.
25. Oberdörster G., Stone V., Donaldson K. Toxicology of nanoparticles: a historical perspective. Nanotoxicology 2007, 1:2-25.
26. Panyam J., Sahoo S.K., Prabha S., Bargar T., Labhasetwar V. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(d, l-lactide-co-glycolide) nanoparticles. International Journal of Pharmaceutics 2003, 262:1-11.
27. Paur H.R., Mülhopt S., Weiss C., Diabaté S. In vitro exposure systems and bioassays for the assessment of toxicity of nanoparticles to the human lung. Journal für Verbraucherschutz und Lebensmittelsicherheit 2008, 3:319-329.
28. Penttinen P., Timonen K.L., Tiittanen P., Mirme A., Ruuskanen J., Pekkanen J. Ultrafine particles in urban air and respiratory health among adult asthmatics. European Respiratory Journal 2001, 17:428-435.
29. Pettibone J.M., Adamcakova-Dodd A., Thorne P.S., O'Shaughnessy P.T., Weydert J.A., Grassian V.H. Inflammatory response of mice following inhalation exposure to iron and copper nanoparticles. Nanotoxicology 2008, 2:189-204.
30. Rahman I., Gilmour P.S., Jimenez L.A., Biswas S.K., Antonicelli F., Aruoma O.I. Ergothioneine inhibits oxidative stress- and TNF-α-induced NF-κB activation and interleukin-8 release in alveolar epithelial cells. Biochemical and Biophysical Research Communications 2003, 302:860-864.
31. Rothen-Rutishauser B., Grass R.N., Blank F., Limbach L.K., Mühlfeld C., Brandenberger C., Raemy D.O., Gehr P., Stark W.J. Direct Combination of nanoparticle fabrication and exposure to lung cell cultures in a closed setup as a method to simulate accidental nanoparticle exposure of humans. Environmental Science and Technology 2009, 43:2634-2640.
32. Sager T.M., Porter D.W., Robinson V.A., Lindsley W.G., Schwegler-Berry D.E., Castranova V. Improved method to disperse nanoparticles for in vitro and in vivo investigation of toxicity. Nanotoxicology 2007, 1:118-129.
33. Savi M., Kalberer M., Lang D., Ryser M., Fierz M., Gaschen A., Ricka J., Geiser M. A novel exposure system for the efficient and controlled deposition of aerosol particles onto cell cultures. Environmental Science and Technology 2008, 42:5667-5674.
34. Sayes C.M., Reed K.L., Warheit D.B. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicological Sciences 2007, 97:163-180.
35. Schmoll L.H., Elzey S., Grassian V.H., O'Shaughnessy P.T. Nanoparticle aerosol generation methods from bulk powders for inhalation exposure studies. Nanotoxicology 2009, 3:265-275.
36. Schrand A.M., Rahman M.F., Hussain S.M., Schlager J.J., Smith D.A., Syed A.F. Metal-based nanoparticles and their toxicity assessment. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2010, 2:544-568.
37. Stebounova L., Adamcakova-Dodd A., Kim J., Park H., O'Shaughnessy P., Grassian V., Thorne P. Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Particle and Fibre Toxicology 2011, 8:5.
38. Stern, S.T., McNeil, S.E., 2007. Nanotechnology safety concerns revisited. Toxicol. Sci., kfm 169.
39. Stringer B., Imrich A., Kobzik L. Lung epithelial cell (A549) interaction with unopsonized environmental particulates: quantitation of particle-specific binding and IL-8 production. Experimental Lung Research 1996, 22:495-508.
40. Teeguarden J.G., Hinderliter P.M., Orr G., Thrall B.D., Pounds J.G. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicological Science 2007, 95:300-312.
41. Tetley T.D. Health effects of nanomaterials. Biochemical Society Transactions 2007, 035:527-531.
42. Thorne P.S. Inhalation toxicology models of endotoxin- and bioaerosol-induced inflammation. Toxicology 2000, 152:13-23.
43. Tippe A., Heinzmann U., Roth C. Deposition of fine and ultrafine aerosol particles during exposure at the air/cell interface. Journal of Aerosol Science 2002, 33:207-218.
44. Vanderpool R.W., Rubow K.L. Generation of large, solid, monodisperse calibration aerosols. Aerosol Science and Technology 1988, 9:65-69.
45. Volckens J., Dailey L., Walters G., Devlin R.B. Direct particle-to-cell deposition of coarse ambient particulate matter increases the production of inflammatory mediators from cultured human airway epithelial cells. Environmental Science and Technology 2009, 43:4595-4599.
46. Weichenthal S., Dufresne A., Infante-Rivard C. Indoor ultrafine particles and childhood asthma: exploring a potential public health concern. Indoor Air 2007, 17:81-91.
47. Witherden, I.R., Tetley, T.D., 2001. Isolation and culture of human alveolar type II pneumocytes. Human airway inflammation. In: Rogers, D.F., Donnelly, L.E. (Eds.), Humana Press, pp. 137-146.
48. Wittmaack K. Excessive delivery of nanostructured matter to submersed cells caused by rapid gravitational settling. ACS Nano 2011, 5:3766-3778.
49. Xia T., Kovochich M., Liong M., Mädler L., Gilbert B., Shi H., Yeh J.I., Zink J.I., Nel A.E. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008, 2:2121-2134.